News

Marqeta Investors Urged to Participate in Securities Class Action

Marqeta Investors Urged to Participate in Securities Class Action

Marqeta Investors Reminded of Critical Class Action

Marqeta, Inc. (NASDAQ: MQ) is currently facing a significant class action lawsuit that has drawn the attention of both investors and legal experts. As this situation unfolds, it's crucial for shareholders to remain informed about their rights and options moving forward.

The Allegations of the Case

Robbins LLP is investigating serious allegations against Marqeta, Inc. that center around claims the company failed to properly disclose the impact of regulatory challenges that could potentially derail its business growth. Throughout the class period, which saw many investors buy securities from the company, it is alleged that essential information regarding these regulatory hurdles was deliberately withheld from the public and investors.

Details on the Regulatory Scrutiny

According to the complaint, Marqeta did not disclose critical insights concerning the regulatory environment governing its operations. This omission is believed to have influenced the company's financial guidance for the fourth quarter of 2024 which had to be cut back significantly due to newfound pressures.

Market Reaction

On November 4, 2024, Marqeta publicly announced its third quarter financial results, along with a revision of its fourth-quarter projections. The shift highlighted several changes that became apparent due to the heightened regulatory scrutiny surrounding the banking climate and specific amendments in customer programs. The impact was quite severe, as shares of Marqeta fell by $2.53, translating to a staggering 42.5% drop, culminating in a closing price of $3.42 on November 5, 2024.

What Should Investors Do?

For investors considering their options, it is important to note that you may still have the opportunity to partake in this class action. Those interested in serving as lead plaintiffs must submit their applications by a specified deadline. A lead plaintiff serves as the representative for all class members, guiding the course of litigation.

Understanding Lead Plaintiff Role

Being a lead plaintiff doesn’t obligate you to take an active part in the proceedings; if you prefer to remain passive, your rights as an absent class member will still be intact. This means you can benefit from any potential recovery without participating directly in the case.

Robbins LLP: A Trusted Partner

Robbins LLP has established itself as a key player in shareholder rights litigation and has been committed to supporting shareholders since 2002. Their mission is to help investors reclaim losses and ensure transparency and accountability among corporate executives.

Stay Informed

If you're a shareholder of Marqeta, Inc. and want to keep abreast of developments regarding this class action or wish to receive notifications about potential settlements, it is advisable to register for alerts from Robbins LLP. They offer free services to inform shareholders when significant corporate actions occur, including the outcomes of class actions.

Frequently Asked Questions

What is the status of the class action against Marqeta?

The class action is currently pending, and investors are encouraged to participate if they purchased securities during the defined class period.

How can I become involved in the class action?

Investors wishing to become lead plaintiffs must submit their applications by the court's deadline, though you can remain a passive member as well.

What should I do if I am an investor?

Stay informed about the case and consider your options related to involvement, whether as a lead plaintiff or an absent class member.

What allegations are being made against Marqeta?

The lawsuit alleges that Marqeta failed to disclose regulatory challenges that negatively affected its business outlook, impacting financial projections.

Where can I get updates on the class action?

You can sign up for notifications from Robbins LLP to receive updates on the case and alerts regarding any corporate misconduct.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading

Top 5 Most Recently Viewed Articles

Pasinex Resources Strengthens Leadership and Strategic Direction

Updated Category News Views 129

Pasinex Resources Limited's Leadership Revamp Pasinex Resources Limited, a prominent Canadian mining company focused on maximizing opportunities in the high-grade zinc-lead-silver sector, recently announced significant leadership changes. This initiative is aimed at enhancing its operational efficiency and positioning the company for sustainable growth in the...

Continue Reading
Reitar Logtech Ventures into Strategic Partnership with Solowin

Updated Category News Views 106

Strategic Partnership Announcement Reitar Logtech Holdings Limited (NASDAQ: RITR), a prominent integrated Property-Logistics Technology (PLT) solutions platform in Asia, is excited to share its latest strategic partnership with Solowin Holdings (NASDAQ: SWIN). This partnership marks a significant step towards transforming the logistics landscape through innovative...

Continue Reading
Brandon Ciaccio Appointed as Grasons' Brand President

Updated Category News Views 217

Brandon Ciaccio Takes the Helm as Grasons Brand President Grasons, a premier franchise brand in the estate sales and business liquidation sector, has announced a significant leadership change. Brandon Ciaccio has been appointed as the new Brand President, a move that brings extensive experience in operational growth and leadership to the company. Previously, Ciaccio...

Continue Reading
Exploring the Impact of AI, 5G, and IoT on Payments Today

Updated Category News Views 127

Transformative Technologies Shaping Payment Experiences In an era where technology is at the forefront of commerce, the advances in AI, 5G, and IoT play a pivotal role in redefining how transactions are conducted. The U.S. Payments Forum has recently published a comprehensive white paper titled "Contextual Payments Considering Artificial Intelligence, 5G, and Internet of...

Continue Reading
Chicory Market Expected to Surge to USD 1.4 Billion Soon

Updated Category News Views 63

Understanding the Chicory Market and Its Growth Potential Chicory (Cichorium intybus L.) is a perennial herb that has gained international recognition due to its adaptability and health benefits. This remarkable plant, native to Europe, thrives in various climates worldwide, from northern Africa to the eastern United States and Australia. With a variety of uses, chicory...

Continue Reading